<li>agrimony<p>agrimony increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>agrimony increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>american ginseng<p>american ginseng increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>american ginseng increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amitriptyline<p>amitriptyline increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>amitriptyline increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>amoxapine<p>amoxapine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>amoxapine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>anamu<p>anamu increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.<span><br><br></span>anamu increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>bendroflumethiazide<p>bendroflumethiazide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>bendroflumethiazide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>budesonide<p>budesonide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>budesonide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>chlorothiazide<p>chlorothiazide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>chlorothiazide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>chlorthalidone<p>chlorthalidone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>chlorthalidone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>chromium<p>chromium increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>chromium increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clobetasone<p>clobetasone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>clobetasone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>clomipramine<p>clomipramine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>clomipramine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>clonidine<p>clonidine decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>clonidine, rosiglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.<span><br><br></span>clonidine, metformin. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.<span><br><br></span>clonidine decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.</p></li><li>cornsilk<p>cornsilk increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).<span><br><br></span>cornsilk increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>cortisone<p>cortisone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>cortisone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>cyanocobalamin<p>metformin decreases levels of cyanocobalamin by unspecified interaction mechanism. Minor/Significance Unknown. It may take several years of metformin therapy to develop vitamin B12 deficiency.</p></li><li>cyclopenthiazide<p>cyclopenthiazide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>cyclopenthiazide<p>cyclopenthiazide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>damiana<p>damiana decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.<span><br><br></span>damiana decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>danazol<p>danazol increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>danazol increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>deflazacort<p>deflazacort decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>deflazacort decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>desipramine<p>desipramine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>desipramine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>devil's claw<p>devil's claw increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>devil's claw increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dexamethasone<p>dexamethasone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>dexamethasone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>diltiazem<p>diltiazem will increase the level or effect of metformin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>dosulepin<p>dosulepin increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>dosulepin<p>dosulepin increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>doxepin<p>doxepin increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>doxepin increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>elderberry<p>elderberry increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).<span><br><br></span>elderberry increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (in vitro research).</p></li><li>eucalyptus<p>eucalyptus increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.<span><br><br></span>eucalyptus increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.</p></li><li>famotidine<p>famotidine increases levels of metformin by decreasing renal clearance. Minor/Significance Unknown.</p></li><li>fludrocortisone<p>fludrocortisone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>fludrocortisone<p>fludrocortisone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>fluoxymesterone<p>fluoxymesterone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>fluoxymesterone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>fo-ti<p>fo-ti increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>fo-ti increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>folic acid<p>metformin decreases levels of folic acid by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>forskolin<p>forskolin increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Colenol, a compound found in Coleus root, may stimulate insulin release.</p></li><li>forskolin<p>forskolin increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Colenol, a compound found in Coleus root, may stimulate insulin release.</p></li><li>furosemide<p>metformin decreases levels of furosemide by unspecified interaction mechanism. Minor/Significance Unknown.<span><br><br></span>furosemide increases levels of metformin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>gotu kola<p>gotu kola increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).<span><br><br></span>gotu kola increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>guanabenz<p>guanabenz decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanabenz, rosiglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.<span><br><br></span>guanabenz decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanabenz, metformin. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.</p></li><li>guanfacine<p>guanfacine decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.<span><br><br></span>guanfacine, rosiglitazone. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.<span><br><br></span>guanfacine, metformin. Other (see comment). Minor/Significance Unknown. 
Comment: Decreased symptoms of hypoglycemia.  Mechanism: decreased hypoglycemia induced catecholamine production.<span><br><br></span>guanfacine decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Diminished symptoms of hypoglycemia.</p></li><li>gymnema<p>gymnema increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>gymnema increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>horse chestnut seed<p>horse chestnut seed increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>horse chestnut seed increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>hydrochlorothiazide<p>hydrochlorothiazide will increase the level or effect of metformin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.<span><br><br></span>hydrochlorothiazide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>hydrochlorothiazide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>hydrocortisone<p>hydrocortisone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>hydrocortisone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>imipramine<p>imipramine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>imipramine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>indapamide<p>indapamide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>indapamide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>isoniazid<p>isoniazid decreases effects of rosiglitazone by unspecified interaction mechanism. Minor/Significance Unknown.<span><br><br></span>isoniazid decreases effects of metformin by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>juniper<p>juniper increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).<span><br><br></span>juniper increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>l-methylfolate<p>metformin decreases levels of l-methylfolate by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>lofepramine<p>lofepramine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>lofepramine<p>lofepramine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>lycopus<p>lycopus increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).<span><br><br></span>lycopus increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (theoretical interaction).</p></li><li>maitake<p>maitake increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).<span><br><br></span>maitake increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Increased risk of hypoglycemia (animal research).</p></li><li>maprotiline<p>maprotiline increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>maprotiline increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>memantine<p>memantine will increase the level or effect of metformin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>mesterolone<p>mesterolone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>mesterolone<p>mesterolone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>methyclothiazide<p>methyclothiazide will increase the level or effect of metformin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.<span><br><br></span>methyclothiazide decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>methyclothiazide decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>methylprednisolone<p>methylprednisolone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>methylprednisolone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>methyltestosterone<p>methyltestosterone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>methyltestosterone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>metolazone<p>metolazone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.<span><br><br></span>metolazone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown. Thiazide dosage &gt;50 mg/day may increase blood glucose.</p></li><li>mianserin<p>mianserin increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>mianserin increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>midodrine<p>metformin will increase the level or effect of midodrine by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>nettle<p>nettle increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>nettle<p>nettle increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. (Theoretical interaction).</p></li><li>nifedipine<p>nifedipine increases levels of metformin by enhancing GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>nortriptyline<p>nortriptyline increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>nortriptyline increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>ofloxacin<p>ofloxacin, rosiglitazone. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Potential dysglycemia.<span><br><br></span>metformin will increase the level or effect of ofloxacin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.<span><br><br></span>ofloxacin, metformin. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Potential dysglycemia.</p></li><li>oxandrolone<p>oxandrolone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>oxandrolone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>oxymetholone<p>oxymetholone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>oxymetholone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>pegvisomant<p>pegvisomant increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>pegvisomant increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>potassium acid phosphate<p>potassium acid phosphate increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.<span><br><br></span>potassium acid phosphate increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium chloride<p>potassium chloride increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.<span><br><br></span>potassium chloride increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>potassium citrate<p>potassium citrate increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.<span><br><br></span>potassium citrate increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia.</p></li><li>prednisolone<p>prednisolone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>prednisolone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>prednisone<p>prednisone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>prednisone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>protriptyline<p>protriptyline increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>protriptyline increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>quinine<p>metformin will increase the level or effect of quinine by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>sage<p>sage increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>sage<p>sage increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>stevia<p>stevia increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>stevia increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>sulfamethoxazole<p>sulfamethoxazole will increase the level or effect of metformin by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>testosterone<p>testosterone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone<p>testosterone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone buccal system<p>testosterone buccal system increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>testosterone buccal system increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>testosterone topical<p>testosterone topical increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>testosterone topical increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>tongkat ali<p>tongkat ali increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypoglycemia.<span><br><br></span>tongkat ali increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Risk of hypoglycemia.</p></li><li>trazodone<p>trazodone increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>trazodone increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>triamcinolone<p>triamcinolone decreases effects of rosiglitazone by pharmacodynamic antagonism. Minor/Significance Unknown.<span><br><br></span>triamcinolone decreases effects of metformin by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>triamterene<p>metformin will increase the level or effect of triamterene by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>trimipramine<p>trimipramine increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>trimethoprim<p>metformin will increase the level or effect of trimethoprim by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li><li>trimipramine<p>trimipramine increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>vanadium<p>vanadium increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown.<span><br><br></span>vanadium increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown.</p></li><li>verapamil<p>metformin will increase the level or effect of verapamil by  basic (cationic) drug competition for renal tubular clearance. Minor/Significance Unknown.</p></li>